Richard Zellars named chair of radiation oncology at IU School of Medicine

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

RICHARD ZELLARS was named professor and chair of radiation oncology at the Indiana University School of Medicine, pending approval by the IU trustees. He will begin his new duties in January.

Zellars is a breast cancer research and associate professor of radiation oncology at The Johns Hopkins University, and is assistant director of clinical trial accrual at the Sidney Kimmel Comprehensive Cancer Center. He previously held faculty positions at the University of Texas Health Science Center at San Antonio and Georgetown University.

Zellars’ research focuses on the safety and efficacy of radiation for the treatment of breast cancer. He also does research into health care disparities in African-American women who typically have more severe radiation toxicities. He also founded the Cancer in the Under-Privileged, Indigent or Disadvantaged Summer Fellowship, which exposes first-year medical students who have a demonstrated interest in serving disadvantaged populations to the specialty of oncology.

YOU MAY BE INTERESTED IN

Those of us who have devoted our careers to treating recalcitrant cancers know the heartbreak of walking alongside an individual facing an advanced diagnosis. We not only shoulder the clinical responsibility, but also the emotional weight that accompanies every step of that journey as each patient’s story becomes connected to our own.
If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login